Measles, mumps, rubella and varicella vaccine - Cadila Healthcare

Drug Profile

Measles, mumps, rubella and varicella vaccine - Cadila Healthcare

Alternative Names: MMR varicella zoster virus vaccine - Cadila Healthcare

Latest Information Update: 17 Mar 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Cadila Healthcare
  • Class Measles vaccines; Rubella vaccines; Varicella vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase I Measles; Mumps; Rubella; Varicella zoster virus infections

Most Recent Events

  • 30 Dec 2015 Cadila Healthcare completes a phase I trial in Measles, Rubella, Mumps and Varicella zoster virus infections (Prevention, In volunteers) in India (SC) (CTRI/2015/10/006291)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top